Cover Image
Market Research Report

Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User - Global Forecast to 2025

Published by MarketsandMarkets Product code 924490
Published Content info 228 Pages
Delivery time: 1-2 business days
Price
Back to Top
Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User - Global Forecast to 2025
Published: February 6, 2020 Content info: 228 Pages
Description

"The global transplant diagnostics market is projected to grow at a CAGR of 7.2% during the forecast period."

The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%. The demand for transplant diagnostic products is expected to grow due to technological advancements in the field of transplant diagnostics and increasing public-private funding for target research activities. The transplant diagnostics market is segmented on product, technology, application, transplant type, end user, and region.

"The independent reference laboratories segment accounted for the largest share of the transplant diagnostics market, by end user, in 2019."

Based on end user, the transplant diagnostics market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2019, independent reference laboratories accounted for the largest share of the transplant diagnostics market due to rapid modernization and automation in diagnostic laboratories, the growing number of R&D activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.

"The molecular assay technologies segment accounted for the largest share of the transplant diagnostics market, by technology, in 2019."

The transplant diagnostics market, by technology, is segmented into molecular (PCR-based assay and sequencing-based assay technologies) and non-molecular assay technologies. In 2019, the molecular assay technologies segment accounted for the largest share of the transplant diagnostics market due to the benefits of molecular assays such as low turnaround times, high procedural efficacy, and real-time sample analysis.

"North America accounted for the largest share of the transplant diagnostics market in 2019."

North America accounted for the largest share of the transplant diagnostics market in 2019, followed by Europe. This can primarily be attributed to the wide availability of advanced transplant diagnostic technologies, well-established distribution channels, and significant public awareness about the clinical benefits of diagnostic products in risk assessment for donors and recipients during transplantations.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%)
  • By Designation: C-level (10%), Director-level (14%), and Others (76%)
  • By Region: North America (40%), Europe (32%), APAC (20%), and RoW (8%)

Some of the prominent players in the transplant diagnostics market are: Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), bioMerieux (France), Becton, Dickinson and Company (US), and Omixon (Hungary).

Research Coverage:

This report studies the transplant diagnostics market based on product, technology, application, transplant type, end user, and region. It studies major factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to five major regions and their respective major countries.

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the transplant diagnostics market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Table of Contents
Product Code: MD 4870

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY RESEARCH
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 PROCEDURE-BASED MARKET ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 TRANSPLANT DIAGNOSTICS MARKET OVERVIEW
  • 4.2 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY
  • 4.3 REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION
  • 4.4 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2019
  • 4.5 REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
  • 4.6 REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE
  • 4.7 TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 KEY MARKET DRIVERS
      • 5.2.1.1 Increasing number of transplant procedures
      • 5.2.1.2 Technological advancements in the field of transplant diagnostics
      • 5.2.1.3 Increasing public-private funding for target research activities
      • 5.2.1.4 Increasing prevalence of infectious diseases
    • 5.2.2 KEY MARKET RESTRAINTS
      • 5.2.2.1 High procedural cost of NGS- and PCR-based diagnostic assays
      • 5.2.2.2 Limited reimbursements for target procedures
    • 5.2.3 KEY MARKET OPPORTUNITIES
      • 5.2.3.1 Rising adoption of cross-matching and chimerism testing during pre- & post-transplantation
      • 5.2.3.2 Growing public awareness about organ donation and transplantation
    • 5.2.4 KEY MARKET CHALLENGES
      • 5.2.4.1 Significant gap between the number of organ donors and organs required annually
      • 5.2.4.2 Procedural and technical limitations associated with donor-recipient screening

6 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
  • 6.2 MOLECULAR ASSAY TECHNOLOGIES
    • 6.2.1 PCR-BASED MOLECULAR ASSAYS
      • 6.2.1.1 Sequence-specific oligonucleotide-PCR
        • 6.2.1.1.1 SSO-PCR is the most widely adopted technique in the PCR-based molecular assays market
      • 6.2.1.2 Sequence-specific primer-PCR
        • 6.2.1.2.1 Growing public-private investments for research activities to support market growth
      • 6.2.1.3 Real-time PCR
        • 6.2.1.3.1 Real-time PCR requires smaller sample volumes as compared to conventional PCR technologies
      • 6.2.1.4 Other PCR-based molecular assays
    • 6.2.2 SEQUENCING-BASED MOLECULAR ASSAYS
      • 6.2.2.1 Sanger sequencing
        • 6.2.2.1.1 Sanger sequencing segment to register the highest growth in the sequencing-based molecular assays market
      • 6.2.2.2 Next-generation sequencing
        • 6.2.2.2.1 Low turnaround time & high throughput sequencing are the major factors supporting the adoption of NGS
      • 6.2.2.3 Other sequencing-based molecular assays
  • 6.3 NON-MOLECULAR ASSAY TECHNOLOGIES
    • 6.3.1 REPLACEMENT OF NON-MOLECULAR ASSAY TECHNIQUES WITH DNA-BASED TECHNIQUES IS EXPECTED TO HAMPER MARKET GROWTH

7 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE

  • 7.1 INTRODUCTION
  • 7.2 REAGENTS & CONSUMABLES
    • 7.2.1 REAGENTS & CONSUMABLES-THE LARGEST & FASTEST-GROWING SEGMENT IN THE TRANSPLANT DIAGNOSTICS MARKET
  • 7.3 INSTRUMENTS
    • 7.3.1 INCREASING PUBLIC-PRIVATE INVESTMENTS WILL SUPPORT MARKET GROWTH
  • 7.4 SOFTWARE & SERVICES
    • 7.4.1 GROWING AUTOMATION & DIGITALIZATION OF DIAGNOSTIC LABORATORY PROCEDURES ARE SUPPORTING MARKET GROWTH

8 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 DIAGNOSTIC APPLICATIONS
    • 8.2.1 PRE-TRANSPLANTATION DIAGNOSTICS
      • 8.2.1.1 Infectious disease testing
        • 8.2.1.1.1 Growing adoption of advanced molecular techniques for pathogen detection to drive market growth
      • 8.2.1.2 Histocompatibility testing
        • 8.2.1.2.1 Technological advancements and growing R&D activities indicate strong growth potential in this segment
      • 8.2.1.3 Blood profiling
        • 8.2.1.3.1 Growing availability of molecular assay products has supported market growth
    • 8.2.2 POST-TRANSPLANTATION DIAGNOSTICS
      • 8.2.2.1 Greater risk of disorders & infections post-transplantation makes diagnostics a necessary step
  • 8.3 RESEARCH APPLICATIONS
    • 8.3.1 GROWING FUNDING FOR RESEARCH HAS DRIVEN MARKET GROWTH

9 TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE

  • 9.1 INTRODUCTION
  • 9.2 SOLID ORGAN TRANSPLANTATION
    • 9.2.1 KIDNEY TRANSPLANTATION
      • 9.2.1.1 Market growth is mainly driven by rising kidney disease prevalence
    • 9.2.2 LIVER TRANSPLANTATION
      • 9.2.2.1 Growing patient population with chronic liver diseases and increasing procedural volume are the key indicators of market growth
    • 9.2.3 LUNG TRANSPLANTATION
      • 9.2.3.1 Rising prevalence of chronic lung disease is a key growth driver of this market segment
    • 9.2.4 HEART TRANSPLANTATION
      • 9.2.4.1 Rising procedural volume indicates strong growth prospects
    • 9.2.5 PANCREAS TRANSPLANTATION
      • 9.2.5.1 Procedural complexity and the risk of surgical complications have restrained the demand for market products in this segment
    • 9.2.6 OTHER ORGAN TRANSPLANTATIONS
  • 9.3 STEM CELL TRANSPLANTATION
    • 9.3.1 RISING PROCEDURAL VOLUME AND GROWING RESEARCH ACTIVITIES ARE DRIVING THE GROWTH OF THE MARKET
  • 9.4 SOFT TISSUE TRANSPLANTATION
    • 9.4.1 TECHNOLOGICAL ADVANCEMENTS AND RISING PREVALENCE OF TARGET DISEASES HAVE DRIVEN MARKET GROWTH
  • 9.5 BONE MARROW TRANSPLANTATION
    • 9.5.1 DEARTH OF WELL-TRAINED SURGEONS TO PERFORM BONE MARROW TRANSPLANTATION IS EXPECTED TO HINDER MARKET GROWTH

10 TRANSPLANT DIAGNOSTICS MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 INDEPENDENT REFERENCE LABORATORIES
    • 10.2.1 RISING CONSOLIDATION OF DIAGNOSTIC LABORATORIES TO DRIVE MARKET GROWTH
  • 10.3 HOSPITALS & TRANSPLANT CENTERS
    • 10.3.1 GROWING PURCHASING POWER OF HOSPITALS & TRANSPLANT CENTERS HAS RESULTED IN HIGH MARKET GROWTH
  • 10.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
    • 10.4.1 GROWING AWARENESS ABOUT THE GENETIC TECHNIQUES IN TRANSPLANT REJECTION MONITORING TO DRIVE MARKET GROWTH

11 TRANSPLANT DIAGNOSTICS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 Ongoing technological advancements in the field of transplant diagnostics to drive market growth in the US
    • 11.2.2 CANADA
      • 11.2.2.1 Growing availability of transplant diagnostic products to support market growth in Canada
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Germany accounted for the largest share of the European market
    • 11.3.2 UK
      • 11.3.2.1 Rising number of transplantation procedures to drive market growth in the UK
    • 11.3.3 FRANCE
      • 11.3.3.1 Adoption of molecular diagnostic techniques for donor-recipient compatibility testing is increasing in France
    • 11.3.4 SPAIN
      • 11.3.4.1 Rising number of solid organ transplantation procedures to drive market growth in Spain
    • 11.3.5 ITALY
      • 11.3.5.1 Sluggish growth in the Italian healthcare sector in the last few years to restrain market growth
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 CHINA
      • 11.4.1.1 Healthcare infrastructural improvements to support market growth in China
    • 11.4.2 INDIA
      • 11.4.2.1 Increasing number of transplantation procedures to drive market growth in India
    • 11.4.3 JAPAN
      • 11.4.3.1 Significant growth in chronic disease prevalence to support market growth in Japan
    • 11.4.4 AUSTRALIA
      • 11.4.4.1 Rising number of solid organ transplantation procedures to support market growth in Australia
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Government initiatives to introduce medical coverage for transplantation to support market growth in South Korea
    • 11.4.6 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 BRAZIL
      • 11.5.1.1 Brazil accounted for the largest share of the LATAM market
    • 11.5.2 MEXICO
      • 11.5.2.1 Rising medical tourism to support market growth in Mexico
    • 11.5.3 REST OF LATAM
  • 11.6 MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 MARKET SHARE ANALYSIS
  • 12.3 COMPETITIVE SCENARIO
    • 12.3.1 PRODUCT LAUNCHES & ENHANCEMENTS
    • 12.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 12.3.3 ACQUISITIONS
    • 12.3.4 EXPANSIONS
  • 12.4 COMPETITIVE LEADERSHIP MAPPING
    • 12.4.1 VISIONARY LEADERS
    • 12.4.2 INNOVATORS
    • 12.4.3 DYNAMIC DIFFERENTIATORS
    • 12.4.4 EMERGING COMPANIES

13 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 13.1 BECTON, DICKINSON AND COMPANY
  • 13.2 BIOFORTUNA
  • 13.3 BIOMERIEUX SA
  • 13.4 BIO-RAD LABORATORIES
  • 13.5 CAREDX
  • 13.6 F. HOFFMAN-LA ROCHE LIMITED
  • 13.7 GENDX
  • 13.8 HOLOGIC, INC.
  • 13.9 ILLUMINA, INC.
  • 13.10 IMMUCOR, INC.
  • 13.11 LUMINEX CORPORATION
  • 13.12 MERCK KGAA
  • 13.13 OMIXON
  • 13.14 QIAGEN NV
  • 13.15 THERMO FISHER SCIENTIFIC
  • 13.16 EMERGING PLAYERS
    • 13.16.1 ALPHA BIOTECH, LTD.
    • 13.16.2 BAG HEALTHCARE
    • 13.16.3 HANSA BIOPHARMA AB
    • 13.16.4 HISTOGENETICS LLC
    • 13.16.5 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 AVAILABLE CUSTOMIZATIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1 PUBLIC-PRIVATE INVESTMENTS AND RESEARCH GRANTS FOR THE DEVELOPMENT OF TRANSPLANT DIAGNOSTIC PRODUCTS, 2015-2018
  • TABLE 2 COST OF ASSAYS FOR MAJOR NGS/PCR-BASED GENOMIC TESTS IN EUROPE (AS OF 2017)
  • TABLE 3 MEDICAL REIMBURSEMENTS FOR TRANSPLANTATION PROCEDURES IN THE US (2017)
  • TABLE 4 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 5 TRANSPLANT DIAGNOSTICS MARKET FOR MOLECULAR ASSAY TECHNOLOGIES, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 6 TRANSPLANT DIAGNOSTICS MARKET FOR MOLECULAR ASSAY TECHNOLOGIES, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 7 TRANSPLANT DIAGNOSTICS MARKET FOR MOLECULAR ASSAY TECHNOLOGIES, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 8 TRANSPLANT DIAGNOSTICS MARKET FOR MOLECULAR ASSAY TECHNOLOGIES, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 9 TRANSPLANT DIAGNOSTICS MARKET FOR MOLECULAR ASSAY TECHNOLOGIES, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 10 TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 11 TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 12 TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 13 TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 14 TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 15 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCE-SPECIFIC OLIGONUCLEOTIDE-PCR, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 16 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCE-SPECIFIC PRIMER-PCR, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 17 TRANSPLANT DIAGNOSTICS MARKET FOR REAL-TIME PCR, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 18 TRANSPLANT DIAGNOSTICS MARKET FOR OTHER PCR-BASED MOLECULAR ASSAYS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 19 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 20 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 21 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 22 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 23 TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 24 TRANSPLANT DIAGNOSTICS MARKET FOR SANGER SEQUENCING, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 25 TRANSPLANT DIAGNOSTICS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 26 TRANSPLANT DIAGNOSTICS MARKET FOR OTHER SEQUENCING-BASED MOLECULAR ASSAYS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 27 TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAY TECHNOLOGIES, BY PRODUCT, 2017-2025 (USD MILLION)
  • TABLE 28 TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAY TECHNOLOGIES, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 29 TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAY TECHNOLOGIES, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 30 TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAY TECHNOLOGIES, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 31 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 32 TRANSPLANT DIAGNOSTICS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 33 TRANSPLANT DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 34 TRANSPLANT DIAGNOSTICS MARKET FOR SOFTWARE & SERVICES, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 35 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2019-2025 (USD MILLION)
  • TABLE 36 TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2019-2025 (USD MILLION)
  • TABLE 37 TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 38 PRE-TRANSPLANTATION DIAGNOSTICS MARKET, BY TYPE, 2019-2025 (USD MILLION)
  • TABLE 39 PRE-TRANSPLANTATION DIAGNOSTICS MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 40 INFECTIOUS DISEASE TESTING APPLICATIONS MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 41 HISTOCOMPATIBILITY TESTING APPLICATIONS MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 42 BLOOD PROFILING APPLICATIONS MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 43 POST-TRANSPLANTATION DIAGNOSTICS MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 44 TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 45 TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2019-2025 (USD MILLION)
  • TABLE 46 SOLID ORGAN TRANSPLANTATION MARKET, BY TYPE, 2019-2025 (USD MILLION)
  • TABLE 47 SOLID ORGAN TRANSPLANTATION MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 48 KIDNEY TRANSPLANTATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 49 LIVER TRANSPLANTATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 50 LUNG TRANSPLANTATION MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 51 HEART TRANSPLANTATION MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 52 PANCREAS TRANSPLANTATION MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 53 OTHER ORGAN TRANSPLANTATIONS MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 54 STEM CELL TRANSPLANTATION MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 55 SOFT TISSUE TRANSPLANTATION MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 56 BONE MARROW TRANSPLANTATION MARKET, BY REGION, 2019-2025 (USD MILLION)
  • TABLE 57 TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 58 TRANSPLANT DIAGNOSTICS MARKET FOR INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 59 TRANSPLANT DIAGNOSTICS MARKET FOR HOSPITALS & TRANSPLANT CENTERS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 60 TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 61 TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 62 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 63 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 64 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 65 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 66 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 67 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 68 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2017-2025 (USD MILLION)
  • TABLE 69 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 70 US: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 71 US: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 72 US: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 73 CANADA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 74 CANADA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 75 CANADA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 76 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 77 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 78 EUROPE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 79 EUROPE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 80 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 81 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 82 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2017-2025 (USD MILLION)
  • TABLE 83 EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 84 GERMANY: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 85 GERMANY: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 86 GERMANY: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 87 NUMBER OF ORGAN TRANSPLANTATION PROCEDURES PERFORMED IN THE UK, 2015 VS. 2018
  • TABLE 88 UK: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 89 UK: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 90 UK: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 91 FRANCE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 92 FRANCE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 93 FRANCE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 94 SPAIN: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 95 SPAIN: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 96 SPAIN: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 97 ITALY: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 98 ITALY: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 99 ITALY: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 100 ROE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 101 ROE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 102 ROE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2017-2025 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 111 NUMBER OF ORGAN TRANSPLANTATION PROCEDURES PERFORMED IN CHINA, 2015 VS. 2018
  • TABLE 112 CHINA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 113 CHINA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 114 CHINA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 115 INDIA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 116 INDIA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 117 INDIA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 118 JAPAN: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 119 JAPAN: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 120 JAPAN: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 121 AUSTRALIA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 122 AUSTRALIA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 123 AUSTRALIA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 124 SOUTH KOREA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 125 SOUTH KOREA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 126 SOUTH KOREA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 127 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 128 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 129 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 130 LATAM: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 131 LATAM: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 132 LATAM: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 133 LATAM: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 134 LATAM: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 135 LATAM: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 136 LATAM: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2017-2025 (USD MILLION)
  • TABLE 137 LATAM: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 138 BRAZIL: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 139 BRAZIL: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 140 BRAZIL: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 141 MEXICO: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 142 MEXICO: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 143 MEXICO: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 144 ROLATAM: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 145 ROLATAM: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 146 ROLATAM: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 147 MEA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  • TABLE 148 MEA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 149 MEA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2017-2025 (USD MILLION)
  • TABLE 150 MEA: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017-2025 (USD MILLION)
  • TABLE 151 MEA: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
  • TABLE 152 MEA: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2017-2025 (USD MILLION)
  • TABLE 153 MEA: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2017-2025 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARIES: GLOBAL TRANSPLANT DIAGNOSTICS MARKET
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4 MARKET SIZE ESTIMATION: TRANSPLANT DIAGNOSTICS MARKET
  • FIGURE 5 DATA TRIANGULATION METHODOLOGY
  • FIGURE 6 REAGENTS & CONSUMABLES WILL CONTINUE TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET IN 2025
  • FIGURE 7 SEQUENCE-SPECIFIC OLIGONUCLEOTIDE-PCR SEGMENT WILL DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET IN 2025
  • FIGURE 8 KIDNEY TRANSPLANTATION SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
  • FIGURE 9 INFECTIOUS DISEASE TESTING SEGMENT DOMINATES THE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION
  • FIGURE 10 INDEPENDENT REFERENCE LABORATORIES-THE FASTEST-GROWING END-USER SEGMENT IN THE TRANSPLANT DIAGNOSTICS MARKET
  • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE TRANSPLANT DIAGNOSTICS MARKET
  • FIGURE 12 RISING NUMBER OF TRANSPLANTATION PROCEDURES WILL DRIVE THE DEMAND FOR TRANSPLANT DIAGNOSTIC PRODUCTS DURING THE FORECAST PERIOD
  • FIGURE 13 PCR-BASED MOLECULAR ASSAYS TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 14 INFECTIOUS DISEASE TESTING AND HISTOCOMPATIBILITY TESTING SEGMENTS TO WITNESS HIGH GROWTH IN THE ASIA PACIFIC MARKET
  • FIGURE 15 INDEPENDENT REFERENCE LABORATORIES WILL DOMINATE THE ASIA PACIFIC TRANSPLANT DIAGNOSTICS END-USER MARKET IN 2019
  • FIGURE 16 NORTH AMERICA WAS THE LARGEST MARKET FOR ALL PRODUCTS & SERVICES IN 2019
  • FIGURE 17 KIDNEY TRANSPLANTATION SEGMENT TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18 CHINA IS ESTIMATED TO BE THE FASTEST-GROWING TRANSPLANT DIAGNOSTICS MARKET
  • FIGURE 19 TRANSPLANT DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 NUMBER OF KIDNEY TRANSPLANTATION PROCEDURES IN MAJOR COUNTRIES, 2013 VS. 2018
  • FIGURE 21 NUMBER OF LIVER TRANSPLANTATION PROCEDURES IN MAJOR COUNTRIES, 2013 VS. 2018
  • FIGURE 22 NUMBER OF LUNG TRANSPLANTATION PROCEDURES IN MAJOR COUNTRIES, 2013 VS. 2018
  • FIGURE 23 NUMBER OF HEART TRANSPLANTATION PROCEDURES IN MAJOR COUNTRIES, 2013 VS. 2018
  • FIGURE 24 NUMBER OF PANCREAS TRANSPLANTATION PROCEDURES IN MAJOR COUNTRIES, 2013 VS. 2018
  • FIGURE 25 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 26 SOLID ORGAN TRANSPLANTATIONS PERFORMED IN THE US, 2015-2019
  • FIGURE 27 SOLID ORGAN TRANSPLANTATION PROCEDURES PERFORMED IN CANADA, 2015-2018
  • FIGURE 28 EUROPE: TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 29 ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 30 NUMBER OF SOLID ORGAN TRANSPLANTATION PROCEDURES PERFORMED IN JAPAN, 2015-2018
  • FIGURE 31 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2016 TO 2019
  • FIGURE 32 BIO-RAD LABORATORIES HELD THE LEADING POSITION IN THE TRANSPLANT DIAGNOSTICS MARKET
  • FIGURE 33 TRANSPLANT DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
  • FIGURE 34 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
  • FIGURE 35 BIOMERIEUX SA: COMPANY SNAPSHOT (2018)
  • FIGURE 36 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2018)
  • FIGURE 37 CAREDX: COMPANY SNAPSHOT (2018)
  • FIGURE 38 F. HOFFMAN-LA ROCHE LIMITED: COMPANY SNAPSHOT (2018)
  • FIGURE 39 HOLOGIC, INC.: COMPANY SNAPSHOT (2019)
  • FIGURE 40 ILLUMINA, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 41 IMMUCOR, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 42 LUMINEX CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT (2018)
  • FIGURE 44 QIAGEN NV: COMPANY SNAPSHOT (2018)
  • FIGURE 45 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2018)
Back to Top